Antibiotic Stewardship Guidelines
Introduction to Antibiotic Classification
- The World Health Organization (WHO) recommends implementing the AWaRe (Access, Watch, Reserve) classification system to simplify antibiotic use in clinical practice, which categorizes antibiotics based on their resistance potential and preserves critical medications while ensuring appropriate treatment 1
- The AWaRe system includes three categories: Access antibiotics (first-line options with lower resistance potential), Watch antibiotics (higher resistance potential, targets for stewardship), and Reserve antibiotics (last-resort options for multidrug-resistant infections) 1
Antibiotic Selection and Use
- Limit the number of antibiotic options for each infection and prioritize antibiotics that can be used for multiple infections to facilitate procurement, access, and clinical decision-making 1
- Adjust antibiotics according to culture results and susceptibility testing, and stop vancomycin or other gram-positive coverage after 2 days if no evidence of gram-positive infection 2, 3
- Transition stable hospitalized patients to oral antibiotics when appropriate, and consider outpatient management for selected low-risk patients 3
- Use oral fluoroquinolone prophylaxis for high-risk neutropenic patients 2
- Base empiric regimens on local antibiograms specific to the hospital population, and choose one gram-positive and one or two gram-negative agents based on local resistance patterns for ventilator-associated pneumonia 4
- De-escalate therapy once culture results are available 4
First-line options for antibiotic therapy include:
Antibiotic Dosage Amoxicillin/Clavulanate 2g/0.2g every 8 hours Eravacyclina 1mg/kg every 12 hours Tigecycline 100mg loading dose, then 50mg every 12 hours Alternative options include:
Antibiotic Dosage Piperacillin/Tazobactam 6g/0.75g loading dose, then 4g/0.5g every 6 hours or 16g/2g in continuous infusion Eravacyclina 1mg/kg every 12 hours Ertapenem 1g every 24 hours Meropenem 1g every 6 hours in extended or continuous infusion Doripenem 500mg every 8 hours in extended or continuous infusion Imipenem/Cilastatin 500mg every 6 hours in extended infusion
Duration of Antibiotic Therapy
- For documented infections, continue antibiotics for the duration of neutropenia (until ANC > 500 cells/mm³) 2
- For unexplained fever in neutropenic patients, continue antibiotics until clear signs of marrow recovery 2
- Limit antibiotic therapy to 3-5 days for intra-abdominal infections with adequate source control 6
- Documented Severe Skin and Soft Tissue Infections (SSTIs) should be treated for 7-14 days based on isolated organisms 7
- Uncomplicated SSTIs should be treated for 7-14 days based on clinical response 7
Assessment and Reassessment of Infection Severity
- Review hospital antibiogram and consider prevalence of MRSA and resistant gram-negative organisms when selecting empiric therapy 4
- Select appropriate antibiotic category based on infection severity and patient risk factors, with first choice being Access antibiotics, second choice being Watch antibiotics, and last resort being Reserve antibiotics 1
- Reassess antibiotic therapy within 48-72 hours and de-escalate based on culture results, consider IV to oral switch if patient is stable, and discontinue unnecessary coverage 2, 3
- Elevated laboratory markers such as abnormal white blood cell count, left shift, elevated C-reactive protein, or procalcitonin may suggest bacterial infection, according to the World Journal of Emergency Surgery guidelines 5
- The assessment of vital signs using the NEWS2 score is crucial for stratifying risk in patients, as recommended by the BMJ 8
Timing of Antibiotic Administration
- Critically ill patients (NEWS2 score indicating high risk) require prompt antibiotic administration, as recommended by the BMJ guidelines 8
- Moderate risk of severe illness based on NEWS2 score requires antibiotic administration within 3 hours, according to the BMJ guidelines 8
- Low risk of severe illness based on NEWS2 score requires antibiotic administration within 6 hours if indicated, as stated by the BMJ guidelines 8
- High-risk patients should receive antibiotics within 1 hour, according to the BMJ guidelines 8
- Delayed administration of antibiotics (more than 24 hours after perforation) can significantly increase mortality, as suggested by 9
Special Considerations
- Uncomplicated superficial abscesses and surgical site infections with minimal systemic signs do not need antibiotics, according to the Clinical Infectious Diseases guidelines 7
- Necrotizing infections require immediate surgical consultation and broad-spectrum antibiotics, as recommended by the Clinical Infectious Diseases guidelines 7
- Community-acquired pneumonia requires antibiotics based on clinical picture, distinguishing between upper vs. lower respiratory tract involvement, and presence of underlying disease or risk factors, as stated by the Clinical Microbiology and Infection guidelines 10
- Viral respiratory infections, including uncomplicated acute bronchitis, should not be treated with antibiotics, as recommended by the American Academy of Family Physicians 11
- Asymptomatic fluid collections in stable patients should not be treated with antibiotics, according to the European Society of Gastrointestinal Endoscopy 12
- Routine antibiotics are NOT recommended for COVID-19 patients, according to the Journal of Microbiology, Immunology and Infection guidelines 13
- MRSA coverage with linezolid, daptomycin, or ceftaroline is recommended when indicated, as suggested by the Infectious Diseases Society of America 7